Orphan-Drug-Designation finalised
Oncoscience AG announces that it finalised the Orphan-Drug-Designation for its monoclonal antibody h-R3 (Theraloc) with the European Agency (Emea) on June, 24th 2004. Oncoscience AG is waiting for a decision within the next three months.